The Long Journey of mTOR Inhibitors and the Long Path That Is Still Ahead.
作者信息
Tedesco Silva Helio
出版信息
Transplantation. 2018 Feb;102(2S Suppl 1):S1-S2. doi: 10.1097/TP.0000000000001950.
PMID:29369969
Abstract
摘要
相似文献
1
The Long Journey of mTOR Inhibitors and the Long Path That Is Still Ahead.mTOR抑制剂的漫长历程以及仍在前方的漫长道路。
Transplantation. 2018 Feb;102(2S Suppl 1):S1-S2. doi: 10.1097/TP.0000000000001950.
2
mTOR Inhibition and Clinical Transplantation: Kidney.mTOR抑制与临床移植：肾脏
Transplantation. 2018 Feb;102(2S Suppl 1):S17-S18. doi: 10.1097/TP.0000000000001692.
3
mTOR Inhibition and Clinical Transplantation: Heart.mTOR 抑制与临床移植：心脏。
Transplantation. 2018 Feb;102(2S Suppl 1):S27-S29. doi: 10.1097/TP.0000000000001921.
4
mTOR Inhibition and Clinical Transplantation: Pancreas and Islet.mTOR 抑制与临床移植：胰腺和胰岛。
Transplantation. 2018 Feb;102(2S Suppl 1):S30-S31. doi: 10.1097/TP.0000000000001700.
5
mTOR Inhibition and Kidney Diseases.mTOR 抑制与肾脏疾病
Transplantation. 2018 Feb;102(2S Suppl 1):S32-S40. doi: 10.1097/TP.0000000000001729.
6
Transplantation: time to rethink immunosuppression by mTOR inhibitors?移植：重新思考 mTOR 抑制剂免疫抑制的时机？
Nat Rev Nephrol. 2009 Nov;5(11):611-2. doi: 10.1038/nrneph.2009.168.
7
Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.mTOR-I 对生育和妊娠的影响：现状和文献回顾。
Expert Rev Clin Immunol. 2013 Aug;9(8):781-9. doi: 10.1586/1744666X.2013.824243.
8
mTOR Inhibition and Cardiovascular Diseases: Cardiac Hypertrophy.mTOR 抑制与心血管疾病：心肌肥厚。
Transplantation. 2018 Feb;102(2S Suppl 1):S41-S43. doi: 10.1097/TP.0000000000001691.
9
Sirolimus, the first mTOR inhibitor.西罗莫司，首个雷帕霉素靶蛋白抑制剂。
Nefrologia. 2006;26 Suppl 2:21-32.
10
Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients.心脏移植患者中mTOR抑制剂及其他免疫抑制剂的预防性使用。
Cell Mol Immunol. 2015 Jan;12(1):122-4. doi: 10.1038/cmi.2014.27. Epub 2014 Jun 2.
Zotero 插件